FDA 1571 Investigational New Drug Application

Investigational New Drug Regulations

FDA-1571 updates

CBER: Part 312 Subpart A - General Provisions; including applicability of requirements and requests for waivers

OMB: 0910-0014

Document [html]
Download: html
File Typeinode/x-empty
File Modified0000-00-00
File Created0000-00-00

© 2025 OMB.report | Privacy Policy